Gene fragment synthesis

The University of Virginia awarded contract A207_PO-0477727-V2 to Twist Bioscience Corporation on September 14, 2026, for the provision of gene fragment synthesis services. The contract encompasses the delivery of 2,840 gene fragments at a unit price of $0.07 each, resulting in a total contract value of $198. The deliverables are designated for receipt by Zefan Li.

This procurement represents a specialized scientific supply arrangement within Virginia's higher education sector. The contract documents specify gene fragment synthesis as the primary deliverable, a service essential for molecular biology research and development applications. No specific period of performance, annual value breakdown, or county designation is provided in the available contract documentation. The relatively modest cumulative value suggests this may represent a limited-quantity purchase order or initial phase of a broader research initiative at the University of Virginia.